RxDoctor Payments Data

Richard Temblador

Medical · Coats, NCNPI 1588638951

Payments from drug & device makers

$1,843in general payments, 2019–2025

Across 104 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$413
  • AbbVie$278
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$120
  • Neurocrine Biosciences, Inc.$82
  • Lilly USA, LLC$78
  • Amgen$65
  • plus $805 from 28 others

What the payments were for

  • Food & beverage$1,843100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,843 in reported general payments places this provider in the 75th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$22,526
Medicare patients
90
Services billed
442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$55,002
MounjaroTirzepatide31$33,553
JardianceEmpagliflozin37$26,508
Xtampza ErOxycodone Myristate58$24,550
LinzessLinaclotide32$24,389
EliquisApixaban28$24,247
Nurtec OdtRimegepant Sulfate18$18,814
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,358
BelbucaBuprenorphine Hcl23$16,836
JanuviaSitagliptin Phosphate12$16,232
TrulicityDulaglutide15$14,056
Repatha SureclickEvolocumab24$13,944
MovantikNaloxegol Oxalate24$13,697
RybelsusSemaglutide11$12,529
Tresiba Flextouch U-200Insulin Degludec15$12,221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$413$67,53159 claims
Lilly USA, LLCMounjaro, Trulicity$78$47,61046 claims
PfizerEliquis, Nurtec Odt$55$43,06146 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$37$41,38681 claims
Boehringer IngelheimJardiance$37$26,50837 claims
AbbVieLinzess$278$24,38932 claims
MerckJanuvia, Belsomra$13$20,91923 claims
GSKTrelegy Ellipta$64$18,35821 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$43$11,14817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 878 medical providers in North Carolina.

Other medical in Coats

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →